Atrial fibrillation and renin-angiotensin system

Therapeutic Advances in Cardiovascular Disease

Volumn 2, Issue 3, 2008, Pages 215-223

  Serra, José Luis ^a   Bendersky, Mario ^b  

^a Sanatorio Allende   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Atrial Fibrillation; Remodeling; Renin Angiotensin System

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATENOLOL; CALCIUM; CALCIUM CHANNEL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ION CHANNEL; LOSARTAN; PERINDOPRIL; PLACEBO; POTASSIUM CHANNEL; TRANDOLAPRIL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT;

ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG RESPONSE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE CONDUCTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE REMODELING; HUMAN; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANIMAL; DRUG EFFECT; HEART ATRIUM; PHYSIOLOGY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HEART ATRIA; HUMANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 59649115053     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944708092111     Document Type: Review

References (94)

1. Ahimastos, A.A. et al. (2005) Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elestogenic remodeling in cell culture. Hypertension 45: 1194-1199.
2. Allessie, M.A. et al. (1985) Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes D.P., Jalife J., eds. Cardiac Electrophysiology and Arrhythmias. NY: Grune & Stratton.
3. Allessie, M.R. et al. (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103: 769-777.
4. Ausma, J. et al. (2003) Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 107: 2051-2058.
5. Ausma, J. et al. (1997) Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96: 3157-3163.
6. Boldt, A. et al. (2003) Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol 42: 1785-1792.
7. Bosch, R.F. et al. (1999) Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovascular Research 44: 121-131.
8. Boyden, P.A. et al. (1984) Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation 69: 1036-1047.
9. Boyden, P.A. et al. (1982) Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. Am J Cardiol 49: 1896-1908.
10. Brasier, A.R. et al. (2002) Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22: 1257-1266.
11. Brilla, C.G. et al. (1990) Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-1364.
12. Brilla, C.G. et al. (1994) Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 26: 809-820.
13. Carnes, S.A. et al. (2001) Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89: e32-e38.
14. Cosio, F.G. and Arribas, F. (1989) Role of conduction disturbances in atrial arrhythmias. In: Attuel P., Coumel P., Janse M.J., eds. The Atrium in Health and Disease. Mount Kisco, NY: Futura Publishing Co.
15. Cosio, F.G. (1994) Intra-atrial conduction and atrial fibrillation. In: Olsson S.B., Allessie M.A., Campbell R.W.F., eds. Atrial Fibrillation: Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co Inc.
16. Cha, T.J. et al. (2004) Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure. Circulation 110: 1520-1526.
17. Cha, T.J. et al. (2004) Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 109: 412-418.
18. Chen, Y. et al. (2001) Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation 104: 2849-2854.
19. Ehrlich, J. et al. (2006) Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 27: 512-518.
20. Engelmann, M.D. and Svendsen, J.H. (2005) Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26: 2083-2092.
21. Franz, M.R. et al. (1997) Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 30: 1785-1792.
22. Frustaci, A. et al. (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96: 1180-1184.
23. Goette, A. et al. (1996) Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 94: 2968-2974.
24. Goette, A. et al. (2000 a) Increased expression of extracellular signal-related kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35: 1669-1677.
25. Goette, A. et al. (2000 b) Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 101: 2678-2681.
26. Gold, R.L. et al. (1986) Amiodarone for refractory atrial fibrillation. Am J Cardiol 57: 124-127.
27. Gramley, F. et al. (2007) Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation. J Cardiovascular Electrophysiology 18: 1076-1082.
28. Grimm, D. et al. (1999) Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat. Cardiovasc Pathol 8: 315-323.
29. Hagendorff, A. et al. (1999) Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99: 1508-1515.
30. Hanatani, A. et al. (1995) Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 27: 1905-1914.
31. Hanna, N. et al. (2004) Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovascular Research 2: 236-244.
32. Hanna, N. et al. (2004) Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 63: 236-244.
33. Hayashi, H. et al. (2002) Aging-related increase to inducible atrial fibrillation in the rat model. J Cardiovasc Electrophysiol 13: 801-808.
34. Healey, J.S. et al. (2005) Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 45: 1832-1839.
35. Henry, W.L. et al. (1976) Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 53: 273-279.
36. Hove-Madsen, L. et al. (2004) Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation 110: 1358-1363.
37. Kass, R.S. and Blair, M.L. (1981) Effects of angiotensin II on membrane current in cardiac Purkinje fibers. J Mol Cell Cardiol 13: 797-809.
38. Kistler, P.M. et al. (2005) Research correspondence: absence of acute effects of angiotensin II on atrial electrophysiology in humans. J Am Coll Cardiol 45: 154-156.
39. Kopecky, S.L. et al. (1987) The natural history of lone atrial fibrillation: a population based study over three decades. N Engl J Med 317: 669-674.
40. Kumagai, K. et al. (2003) Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 41: 2197-2204.
41. Li, D. et al. (1999) Promotion of atrial fibrillation by heart failure in dogs : atrial remodeling of a different sort. Circulation 100: 87-95.
42. Li, D. et al. (2001) Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104: 2608-2614.
43. Lopez, B. et al. (2001) Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 104: 286-291.
44. Matsubara, H. (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83: 1182-1191.
45. Milliez, P. et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243-1248.
46. Moe, G.K. and Abildskov, J.A. (1995) Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 58: 59-70.
47. Moe, G.K. (1962) On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 140: 183-188.
48. Morillo, C.A. et al. (1995) Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 91: 1588-1595.
49. Morris Jr, J.J. et al. (1966) Electrical conversion of atrial fibrillation: immediate and long-term results and selection of patients. Ann Intern Med 65: 216-231.
50. Mukherjee, R. et al. (2006) Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97: 532-537.
51. Murray, K.T. et al. (2004) Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm 1: 669-675.
52. Nakashima, H. et al. (2000) Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101: 2612-2617.
53. Nattel, S. and Ehrlich, J.R. (2004) Atrial Fibrillation in Cardiac Electrophysiolgy: From Cell to Bedside, 4th edition. Zipes, D.P., Jalife, J. eds. Saunders.
54. Ndrepepa, G. et al. (2002) Characterization of paroxysmal and persistent atrial fibrillation in the human left atrium during initiation and sustained episodes. J Cardiovasc Electrophysiol 13: 525-532.
55. Otsuka, S. et al. (1998) Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 32: 467-472.
56. Paradis, P. et al. (2000) Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA. 97: 931-936.
57. Pedersen, O.D. et al. (1999) Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100: 376-380.
58. Pilchmaier, A.M., et al. (1998) Prediction of the onset of atrial fibrillation after cardiac surgery using the monophasic action potential. Heart 80: 467-472.
59. Sadoshima, J. and Izumo, S. (1993) Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT 1 receptor subtype. Circ Res 73: 413-423.
60. Shi, Y. et al. (2001) Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovascular Research 52: 217-225.
61. Shinagawa, K. et al. (2002) Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Cardiovasc Res 54: 438-446.
62. Shinagawa, K. et al. (2002) Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 105: 2672-2678.
63. Sih, H.J. et al. (2000) Differences in organization between acute and chronic atrial fibrillation in dogs. J Am Coll Cardiol 36: 924-931.
64. Sivasubramanian, N. et al. (2001) Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104: 826-831.
65. Smits, J.F. et al. (1992) Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 20: 772-778.
66. Spach, M.S. and Boineau, J.P. (1997) Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol 20: 397-413.
67. Suttorp, M.J. et al. (1990) The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 16: 1722-1727.
68. Tieleman, R.G. et al. (1997) Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 95: 1945-1953.
69. Tillmann, H.C. et al. (2002) Acute effects of aldosterone on intracardiac monophasic action potentials. Int J Cardiol 84: 33-39.
70. Todd, D.M. et al. (2004) Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Circulation 109: 1434-1439.
71. Tsai, C.T. et al. (2004) Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109: 1640-1646.
72. Ueng, K.-C. et al. (2003) Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: results of a prospective and controlled study. Eur Heart J 24: 2090-2098.
73. Urata, H. et al. (1993) Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91: 1269-1281.
74. van der Velden, H.M. et al. (2000) Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 46: 476-486.
75. van Gelder, I.C. et al. (1991) Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 68: 41-46.
76. van Krimpen, C. et al. (1991) DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 23: 1245-1253.
77. van Wagoner, D.R. et al. (1999) Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res 85: 428-436.
78. van Wagoner, D.R. et al. (1997) Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 80: 772-781.
79. van Wagoner, D.R. (2004) Electrical Remodeling and Chronic Atrial Fibrillation in Cardiac Electrophysiolgy: From Cell to Bedside, 4th edition. Zipes, D.P., Jalife, J. eds. Saunders.
80. Verheule, S. et al. (2004) Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-ß1. Circ Res 94: 1458-1465.
81. Verheule, S. et al. (2003) Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 107: 2615-2622.
82. Vermes, E. et al. (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation 107: 2926-2931.
83. Vohra, J.K. et al. (2003) Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108: 1461-1468.
84. Wachtell, W. et al. (2005) Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End point reduction in hypertension (LIFE) study. J Am Coll Cardiol 45: 712-719.
85. Weber, K.T. and Brilla, C.G. (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin- angiotensin-aldosterone system. Circulation 83: 1849-2186.
86. Weber, K.T. et al. (1993) Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 27: 341-348.
87. White, C.W. et al. (1982) The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ Res 51: 205-25.
88. Wijffels, M. et al. (1997) Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 96: 3710-3720.
89. Wijffels, M.C.E.F. et al. (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92: 1954-1968.
90. Willems, R. et al. (2001) Different patterns of angiotensin II and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation. J Cardiovasc Electrophysiol 12: 1387-1392.
91. Xiao, H.D. et al. (2004) Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165: 1019-1032.
92. Yin, Y. et al. (2006) Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. Eur Heart J 27: 1841-1846.
93. Yue, J. et al. (1997) Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81: 512-525.
94. Zrenner, B. et al. (2001) Electrophysiologic characteristics of paroxysmal and chronic atrial fibrillation in human right atrium. J Am Coll Cardiol 38: 1143-1149.